Hubro Therapeutics is Pharmaceuticals in Norway that focus on target neo business. Founded in 2018. They cover business area such as developer, novel cancer vaccine, immunotherapy, activation, target neo, -antigen, genetic frameshift mutation, MSI, patient, their unmet medical condition.
2018
( 6 years old in 2024 )
Target Neo
-
Oslo Cancer Cluster incubator (OCCi), Red Building, 4th floor
Ullernchausséen 64
0379 Oslo
Norway
Private
developernovel cancer vaccineimmunotherapyactivationtarget neo-antigengenetic frameshift mutationMSIpatienttheir unmet medical condition
* We use standard office opening hours in near Hubro Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Hubro Therapeutics is Pharmaceuticals business from Norway that founded in 2018 (6 years old in 2024), Hubro Therapeutics business is focusing on Target Neo.
Hubro Therapeutics headquarter office and corporate office address is located in Oslo Cancer Cluster incubator (OCCi), Red Building, 4th floor Ullernchausséen 64 0379 Oslo Norway.
Hubro Therapeutics was founded in Norway.
In 2024, Hubro Therapeutics is currently focus on target neo sector.
Above is snippet of Google Trends for "target neo" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Hubro Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
